SEC Form 4 · accession 0001213900-16-013724
ORAMED PHARMACEUTICALS INC. · ORMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leonard Sank
Director
Period of report
May 20, 2016
Accepted (ET)
May 23, 2016 · 11:14 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001176309
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 20, 2016 | A | 3,000 | $8.57 | A | 270,896 | D | |
| Common StockF1 | holding | — | — | — | 78,125 | I | Via spouse | |
| Common StockF2 | holding | — | — | — | 138,889 | I | Via trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Mr. Sank disclaims beneficial ownership of these shares.
- F2These shares consist of shares of common stock owned by a company wholly owned by a trust of which Mr. Sank is a trustee. Mr. Sank disclaims beneficial ownership of these shares.